Gyre Therapeutics, Inc. (GYRE) Raises $23M in Public Stock Offering to Fund Liver Fibrosis Trials
Gyre Therapeutics, Inc.
No. | Hedge Fund | Shares | Value | Activity | % Port |
---|---|---|---|---|---|
1. | 0 | $0 | 0% |
Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$0.47 | 3,250 | $1,527.50 | 24,541 | 2022-08-09 | Filing | |
$0.47 | 3,250 | $1,527.50 | 6,500 | 2022-08-09 | Filing | |
$0.47 | 3,250 | $1,527.50 | 9,417 | 2022-08-09 | Filing | |
$0.46 | 3,250 | $1,495.00 | 21,291 | 2022-02-09 | Filing | |
$0.46 | 3,250 | $1,495.00 | 3,250 | 2022-02-09 | Filing |
Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$10.07 | 558 | $5,619.06 | 2,806,084 | 2025-05-28 | Filing | |
$10.28 | 2,000 | $20,560.00 | 2,806,642 | 2025-05-27 | Filing | |
$10.24 | 182 | $1,863.68 | 2,808,642 | 2025-05-23 | Filing | |
$10.97 | 2,000 | $21,940.00 | 2,808,824 | 2025-05-22 | Filing | |
$10.83 | 2,000 | $21,660.00 | 2,810,824 | 2025-05-21 | Filing |